{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:34:58Z","timestamp":1789594498229,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.pcl.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T17:38:29Z","timestamp":1667065109000},"page":"1079-1098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Current Understanding of Nephrotic Syndrome in Children"],"prefix":"10.1016","volume":"69","author":[{"given":"Tej K.","family":"Mattoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Sanjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pcl.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","article-title":"Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children","volume":"13","year":"1978","journal-title":"Kidney Int"},{"issue":"Suppl","key":"10.1016\/j.pcl.2022.08.002_bib2","first-page":"S5","article-title":"Five hundred years of the nephrotic syndrome: 1484-1984","volume":"54","author":"Cameron","year":"1985","journal-title":"Ulster Med J"},{"key":"10.1016\/j.pcl.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fped.2016.00056","article-title":"History of Nephrotic Syndrome and Evolution of its Treatment","volume":"4","author":"Pal","year":"2016","journal-title":"Front Pediatr"},{"key":"10.1016\/j.pcl.2022.08.002_bib4","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"3","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-029249","article-title":"Incidence and Relapse of Idiopathic Nephrotic Syndrome: Meta-analysis","volume":"148","author":"Veltkamp","year":"2021","journal-title":"Pediatrics"},{"issue":"9384","key":"10.1016\/j.pcl.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib7","first-page":"220","article-title":"The familial nephrotic syndrome. II. A clinicopathological study","volume":"1","author":"Moncrieff","year":"1973","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.pcl.2022.08.002_bib8","series-title":"Pediatric nephrology","first-page":"1436","article-title":"Pediatric Nephrology in the Arabian Peninsula","author":"Mattoo","year":"1993"},{"issue":"2","key":"10.1016\/j.pcl.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1152\/physrev.00055.2006","article-title":"Properties of the glomerular barrier and mechanisms of proteinuria","volume":"88","author":"Haraldsson","year":"2008","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2215\/CJN.04121206","article-title":"A\u00a0proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases","volume":"2","author":"Barisoni","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7880","key":"10.1016\/j.pcl.2022.08.002_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","article-title":"Pathogenesis of lipoid nephrosis: a disorder of T-cell function","volume":"2","author":"Shalhoub","year":"1974","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.pcl.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","article-title":"Rituximab therapy for steroid-dependent minimal change nephrotic syndrome","volume":"21","author":"Gilbert","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.pcl.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfu267","article-title":"Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome","volume":"30","author":"Sinha","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.ackd.2014.11.006","article-title":"Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension","volume":"22","author":"Ray","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"7","key":"10.1016\/j.pcl.2022.08.002_bib17","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00467-020-04779-x","article-title":"Mechanisms and management of edema in pediatric nephrotic syndrome","volume":"36","author":"Kallash","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children","volume":"98","year":"1981","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s004670050310","article-title":"Nephrotic syndrome in South African children: changing perspectives over 20 years","volume":"11","author":"Bhimma","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ekir.2019.01.019","article-title":"Nephrotic Syndrome in South African Children: Changing Perspectives in the New Millennium","volume":"4","author":"Nandlal","year":"2019","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00868271","article-title":"Prognostic value of sonography in childhood nephrotic syndrome","volume":"8","author":"Gershen","year":"1994","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.pcl.2022.08.002_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3339\/jkspn.2019.23.2.86","article-title":"Genetic Basis of Steroid Resistant Nephrotic Syndrome","volume":"23","author":"Park","year":"2019","journal-title":"Child Kidney Dis"},{"issue":"6","key":"10.1016\/j.pcl.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A\u00a0single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pcl.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1681\/ASN.V85824","article-title":"Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults","volume":"8","author":"Tune","year":"1997","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000515062","article-title":"A\u00a0Case of Nephrotic Syndrome that Resolved with Influenza B Infection","volume":"11","author":"Tamura","year":"2021","journal-title":"Case Rep Nephrol Dial"},{"issue":"2","key":"10.1016\/j.pcl.2022.08.002_bib26","first-page":"239","article-title":"Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children","volume":"95","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2022.08.002_bib27","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"4","author":"Hodson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A\u00a0multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6\u00a0months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pcl.2022.08.002_bib31","doi-asserted-by":"crossref","first-page":"l1800","DOI":"10.1136\/bmj.l1800","article-title":"Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation","volume":"365","author":"Webb","year":"2019","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib32","first-page":"CD001533","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"2015","author":"Hahn","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.pcl.2022.08.002_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF02761198","article-title":"High dose methylprednisolone therapy in nephrotic syndrome","volume":"66","author":"Mocan","year":"1999","journal-title":"Indian J Pediatr"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2005090922","article-title":"Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial","volume":"17","author":"Hoyer","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00431-013-2192-3","article-title":"A\u00a0prospective randomly controlled clinical trial on azithromycin therapy for induction treatment of children with nephrotic syndrome","volume":"173","author":"Zhang","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"6505","key":"10.1016\/j.pcl.2022.08.002_bib37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1136\/bmj.291.6505.1305","article-title":"Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome","volume":"291","author":"Imbasciati","year":"1985","journal-title":"Br Med J (Clin Res Ed"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00467-018-4149-2","article-title":"Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study","volume":"34","author":"Dossier","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"10.1016\/j.pcl.2022.08.002_bib39","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00467-011-1961-3","article-title":"Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?","volume":"26","author":"Saadeh","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-015-3285-1","article-title":"Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial","volume":"31","author":"Raman","year":"2016","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1016\/j.pcl.2022.08.002_bib41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10157-020-01875-y","article-title":"Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome","volume":"24","author":"Basu","year":"2020","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1016\/j.pcl.2022.08.002_bib42","doi-asserted-by":"crossref","first-page":"e1404","DOI":"10.1542\/peds.2006-2554","article-title":"Serum osmolal gap in patients with idiopathic nephrotic syndrome and severe edema","volume":"119","author":"Kapur","year":"2007","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.pcl.2022.08.002_bib43","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2215\/CJN.04390808","article-title":"Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study","volume":"4","author":"Kapur","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pcl.2022.08.002_bib44","series-title":"Red Book: 2021\u20132024 Report of the Committee on Infectious Diseases","article-title":"Immunizations and other considerations in immunocompromised children","author":"Kimberlin","year":"2021"},{"issue":"8","key":"10.1016\/j.pcl.2022.08.002_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/000992288802700807","article-title":"Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate","volume":"27","author":"Elzouki","year":"1988","journal-title":"Clin Pediatr (Phila)"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00878359","article-title":"Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome","volume":"6","author":"Srivastava","year":"1992","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.pcl.2022.08.002_bib47","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00467-018-4071-7","article-title":"Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial","volume":"34","author":"Yadav","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib48","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000045684","article-title":"Increased maintenance corticosteroids during upper respiratory infection decrease the risk of relapse in nephrotic syndrome","volume":"85","author":"Mattoo","year":"2000","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.01850310","article-title":"Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Gulati","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib50","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/adc.2007.116079","article-title":"Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial","volume":"93","author":"Abeyagunawardena","year":"2008","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.pcl.2022.08.002_bib51","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00467-017-3640-5","article-title":"Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome","volume":"32","author":"Abeyagunawardena","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib52","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1542\/peds.104.4.e51","article-title":"Behavioral effects of corticosteroids in steroid-sensitive nephrotic syndrome","volume":"104","author":"Soliday","year":"1999","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(97)70213-0","article-title":"Management of hyperlipidemia in children with refractory nephrotic syndrome: the effect of statin therapy","volume":"130","author":"Sanjad","year":"1997","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib54","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/ajkd.2003.50116","article-title":"Steroid-sensitive nephrotic syndrome: from childhood to adulthood","volume":"41","author":"Fakhouri","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib55","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00467-018-4119-8","article-title":"Childhood onset steroid-sensitive nephrotic syndrome continues into adulthood","volume":"34","author":"Korsgaard","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF00857660","article-title":"Cystic lymphangiectasia of the kidneys in an infant with nephrotic syndrome","volume":"4","author":"Mattoo","year":"1990","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00857659","article-title":"Familial glomerulopathy with proximal tubular dysfunction: a new syndrome?","volume":"4","author":"Mattoo","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pcl.2022.08.002_bib58","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fped.2019.00404","article-title":"The Search for Biomarkers to Aid in Diagnosis, Differentiation, and Prognosis of Childhood Idiopathic Nephrotic Syndrome","volume":"7","author":"Stone","year":"2019","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.pcl.2022.08.002_bib59","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00467-015-3110-x","article-title":"Nephrotic syndrome and thrombotic microangiopathy caused by cobalamin C deficiency","volume":"30","author":"Koenig","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.pcl.2022.08.002_bib60","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1053\/j.ajkd.2013.12.002","article-title":"Canadian Society of Nephrology Commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis: management of nephrotic syndrome in children","volume":"63","author":"Samuel","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.pcl.2022.08.002_bib61","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00431-021-03958-8","article-title":"Practice variations in the management of childhood nephrotic syndrome in the Netherlands","volume":"180","author":"Schijvens","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pcl.2022.08.002_bib62","first-page":"124","article-title":"Nefrotisch syndroom","volume":"2","author":"Lilien","year":"2010","journal-title":"Werkboek Kindernefrologie"},{"issue":"12","key":"10.1016\/j.pcl.2022.08.002_bib63","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.arcped.2017.09.022","article-title":"[Idiopathic nephrotic syndrome]","volume":"24","author":"Boyer","year":"2017","journal-title":"Arch Pediatr"},{"issue":"10","key":"10.1016\/j.pcl.2022.08.002_bib64","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s00467-021-05135-3","article-title":"Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6\/2020","volume":"36","author":"Ehren","year":"2021","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1016\/j.pcl.2022.08.002_bib65","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","article-title":"Steroid Sensitive Nephrotic Syndrome: Revised Guidelines","volume":"58","author":"Sinha","year":"2021","journal-title":"Indian Pediatr"},{"issue":"1","key":"10.1016\/j.pcl.2022.08.002_bib66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","article-title":"The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse","volume":"43","author":"Pasini","year":"2017","journal-title":"Ital J Pediatr"},{"issue":"8","key":"10.1016\/j.pcl.2022.08.002_bib67","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00467-020-04519-1","article-title":"IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome","volume":"35","author":"Trautmann","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1016\/j.pcl.2022.08.002_bib68","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5414\/CN110435","article-title":"Calcineurin inhibitors and renal biopsy in children with idiopathic nephrotic syndrome","volume":"96","author":"Abukwaik","year":"2021","journal-title":"Clin Nephrol"},{"issue":"8","key":"10.1016\/j.pcl.2022.08.002_bib69","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","article-title":"Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial","volume":"172","author":"Basu","year":"2018","journal-title":"JAMA Pediatr"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395522001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395522001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:26:11Z","timestamp":1758475571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395522001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0031395522001018"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2022.08.002","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Understanding of Nephrotic Syndrome in Children","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}